Chris Sale is the Chief Executive Officer at Nonacus Ltd since May 2015. Prior to this role, Chris worked as a Consultant Genomics Business Manager at Agilent Technologies from May 2014 to April 2018. With a background in Biochemistry and Molecular Biology, Chris has held various sales and management positions in notable companies such as Illumina and Stratagene. Chris has extensive experience in managing commercial business and developing key accounts within the genomics industry.
May, 2015 - present